Interim Analysis Results From A Phase 2 Study Of Sotatercept Administered Intravenously Or Subcutaneously For The Evaluation Of Pharmacokinetics, Safety, And Maintenance Of Hemoglobin In Hemodialysis Subjects
AuthID
P-00K-HWT
P-00K-HWT